Coverage of the satellite symposium session "Emerging treatments for patients with cancer: practical guidelines and expert insights" presented at the European Society for Medical Oncology (ESMO) 2017 Congress on Monday 11 September 2017 in Madrid, Spain.
The symposium was supported by Tesaro,...
Iain McNeish discusses the role of PARP inhibitors, including rucaparib in the treatment of ovarian cancer.
Part 3 of 3 - Dr Domenica Lorusso tells us which presentations, in gynecological cancer, she has found particularly interesting at ASCO 2017.
Speaker disclosures: Advisory Board for Clovis Oncology, Astra Zeneca, PharmaMar, Roche.
Filmed at the American Society of Clinical Oncology (ASCO)...
Coverage of the satellite symposium session "A New PARP Inhibitor to Clinical Practice" presented at ECCO 2017.
The symposium was supported by Tesaro, who provided this video coverage.
Dr Christian Marth discusses neoadjuvant chemotherapy and upfront surgery in ovarian cancer.
FILMED AT THE EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY (ESMO) ANNUAL MEETING, OCTOBER 2016.
Prof Richard Shaw - (University of Liverpool Cancer Research Centre, Liverpool, UK) talks to ecancertv at IAOO 2015 about the Post-operative Adjuvant Treatment for HPV-positive Tumours (PATHOS) trial.